| Section | Status | CCG | Name |
| 13.05.03 | Formulary |  |
Abrocitinib Cibinqo ® |
| 09.01.04 | Formulary | |
Avatrombopag Doptelet® |
| 10.01.03 | Formulary | |
Baricitinib Olumiant® |
| 13.05.03 | Formulary | |
Brodalumab Kyntheum® |
| 11.08.02 | Formulary | |
Brolucizumab Beovu® |
| 10.01.03 | Formulary | |
Certolizumab Pegol Cimzia® |
| 06.01.02.03 | Formulary | |
Dapagliflozin Forxiga® |
| 13.05.03 | Formulary | |
Deucravacitinib SOTYKTU |
| 11.04.01 | Formulary | |
Dexamethasone intravitreal implant Ozurdex® |
| 04.07.04.02 | Formulary | |
Eptinezumab Vyepti® |
| 04.07.04.02 | Formulary | |
Erenumab Aimovig® |
| 06.01.02.03 | Formulary | |
Ertugliflozin Steglatro® |
| 10.01.03 | Formulary | |
Filgotinib Jyseleca® |
| 09.01.04 | Formulary | |
Fostamatinib TAVLESSE ® |
| 04.07.04.02 | Formulary | |
Fremanezumab Ajovy® |
| 04.07.04.02 | Formulary | |
Galcanezumab Emgality® |
| 10.01.03 | Formulary | |
Guselkumab Tremfya® |
| 13.05.03 | Formulary | |
Guselkumab Tremfya® |
| 13.05.02 | Formulary | |
Ixekizumab Taltz® |
| 04.05.01 | Formulary | |
Liraglutide Saxenda® |
| 09.06 | Formulary | |
Paravit CF® |
| 07.04.03 | Formulary | |
Pentosan polysulfate sodium |
| 06.07.02 | Formulary | |
Relugolix–estradiol–norethisterone acetate Ryeqo ® |
| 04.06 | Formulary | |
Rimegepant Vydura |
| 10.01.03 | Formulary | |
Risankizumab Skyrizi® |
| 13.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 10.01.03 | Formulary | |
Sarilumab Kevzara® |
| 04.05.01 | Formulary | |
Semaglutide Wegovy® |
| 09.02.01.01 | Formulary | |
Sodium zirconium cyclosilicate Lokelma® |
| 13.05.03 | Formulary | |
Tildrakizumab Ilumetri® |
| 13.05.03 | Formulary | |
Tralokinumab Adtralza ® |
| 10.01.03 | Formulary | |
Upadacitinib Rinvoq ® |
| 13.05.03 | Formulary | |
Upadacitinib Rinvoq ® |